OPPENHEIMER ASSET MANAGEMENT INC. - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q1 2020$040.0%0.00%
Q4 2019$040.0%0.00%
Q3 2019$040.0%0.00%
Q2 2019$040.0%0.00%
Q1 2019$040.0%0.00%
Q4 2018$0
-100.0%
4
-99.8%
0.00%
-100.0%
Q3 2017$109,000
+39.7%
2,005
+32.7%
0.00%
+50.0%
Q2 2017$78,000
-67.5%
1,511
-60.4%
0.00%
-71.4%
Q1 2017$240,0003,8190.01%
Other shareholders
SEATTLE GENETICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 51,046,060$2,892,270,00023.68%
Lagoda Investment Management, L.P. 88,615$5,021,0008.38%
Matrix Capital Management Company, LP 3,141,852$178,017,0005.90%
Opus Point Partners Management, LLC 19,127$1,084,0002.39%
EMORY UNIVERSITY 41,539$2,354,0001.86%
Capital International Sarl 238,100$13,491,0001.62%
Rhenman & Partners Asset Management AB 242,198$13,723,0001.57%
CAPITAL GUARDIAN TRUST CO 1,341,050$75,984,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 42,500$1,890,0001.17%
JGP Global Gestao de Recursos Ltda. 16,524$936,0001.14%
View complete list of SEATTLE GENETICS INC shareholders